Neurons in the mammalian central nervous system (CNS) cannot regenerate axons after injury. in contrast, neurons in the mammalian peripheral nervous system and in some non-mammalian models, such as C. elegans and Drosophila, are able to regrow axons. Understanding the molecular mechanisms by which these neurons support axon regeneration will help us find ways to enhance mammalian CNS axon regeneration. Here, recent studies in which signaling pathways regulating naturally-occurring axon regeneration that have been identified are reviewed, focusing on how these pathways control gene expression and growth-cone function during axon regeneration.
Introduction
Damage to the central nervous system (CNS), such as spinal cord injury and traumatic brain injury, often results in damage to axons. Unfortunately, mature neurons in the mammalian CNS cannot regenerate axons after injury, leading to irreversible motor, sensory, or cognitive dysfunctions. Therefore, promoting axon regeneration is a major approach to treating these symptoms. one important reason for CNS regeneration failure is the irreversible loss of the intrinsic axon growth capacity of CNS neurons after maturation. To address this issue, recent attempts to augment the growth potential by regulating transcriptional or translational machinery have provided promising results [1] [2] [3] [4] [5] . However, the degree of axon regeneration promoted by these molecular interventions is still rudimentary compared with the regeneration that occurs after injury to the mammalian peripheral nervous system (PNS) or in non-mammals. This fact indicates that understanding the molecular mechanisms by which naturally-occurring axon regeneration is regulated should be a major focus of investigation. The first step would be to elucidate the underlying signaling pathways that regulate naturally-occurring axon regeneration.
Many mature CNS neurons in non-mammals, such as C. elegans, Drosophila, and zebrafish, are able to regenerate after injuries. The powerful genetic approaches available in these species have made them attractive model systems for dissecting the signaling pathways controlling axon regeneration. indeed, recent studies using these systems, in particular C. elegans, have revealed several regeneration signaling pathways in vivo [6] [7] [8] . The mammalian PNS also mounts a robust regenerative response after nerve injury. However, in mice it is difficult to perform similar genetic analysis, which often involves genetic targeting of multiple signaling molecules at the same time, specifically in adult neurons. As a result, we know much less about the signaling pathways that regulate naturally-occurring mammalian axon regeneration in vivo.
Axon extension, during either development or regeneration, comprises several highly-coordinated processes, including gene transcription/expression in the soma, transport of synthesized molecules along the axon, and axon assembly at the growth cone (Fig. 1 initiates a regenerative response [9] . Another approach for injury in live C. elegans is to use a femtosecond laser to perform acute axotomy of fluorescence-labeled neurons [10, 11] . Similar laser axotomy has also been established in Drosophila [12] and zebrafish [13] . Using such in vivo axotomy approaches combined with large-scale genetic screening, recent studies have identified several signaling pathways that control axon regeneration in vivo either at the growth cone or at the soma (Fig. 2 ).
Signaling at the Growth Cone
Growth cones are highly specialized structures at the distal tips of axons that control the rate and direction of axon growth during development. Assembly of the cytoskeletal elements and membrane components at the growth cone drives its advancement and the subsequent axon extension. Formation of a growth cone after axotomy, which is achieved via reorganization of the cytoskeleton at the proximal axonal stump, is the first step for successful regeneration. Both growth-cone formation and advancement are tightly regulated by extracellular factors and intracellular signaling molecules [14, 15] .
Currently, there is no experimental approach in C.
elegans to spatially distinguish signaling events during axon growth. However, based on downstream effectors and the time-courses in observed phenotypes, it seems that the regeneration pathways identified in C. elegans to date act mostly in the axon to control growth-cone formation after axotomy (Fig. 2) . A large-scale RNAi-based genetic screen has identified dual leucine zipper-bearing kinase 1 (DLK-1) as a key regulator of axon regeneration [9] .
Genetic interaction experiments have identified MKK-4
(MAP kinase kinase 4, MAP2K4) and PMK-3 (p38 MAP growth-cone formation after axotomy [9] and the temporal requirement of DLK-1 function for regeneration is very soon after the axotomy, it has been suggested that DLK-1 mainly functions locally at the growth cone to control axon regeneration. in support, a different study has shown that MAK-2 (MAP kinase activated kinase, MAPKAP) acts downstream of DLK-1 to control axon regeneration via controlling the local translation of CEBP-1 in the axon [16] .
To further support the role of DLK-1 in the growth cone, a later study showed that KLP-7 (kinesin-13) and CCPP-6
(cytosolic carboxipeptidase), two proteins directly involved in the regulation of microtubule dynamics, act downstream of DLK-1 to control axon regeneration [17] . Specifically, DLK-1 inhibits KLP-7, which has microtubule depolymerase activity and functions to restrict microtubule assembly. Conversely, DLK-1 activates CCPP-6, which deglutamylates tubulin 
414
and promotes microtubule stabilization. Moreover, another genetic screen study has identified EFA-6, an Arf guanine nucleotide exchange factor, as a negative regulator of axon regeneration via destabilizing axonal microtubules [18] .
Because the loss-of-function mutant of EFA-6 partially bypasses the requirement of DLK-1 for axon regeneration, it is likely that EFA-6 is also a downstream mediator of [19] . The promoting effect of Ca 2+ signaling on axon regeneration is mediated by activation of adenyl cyclase (AC) and the subsequent elevation of cAMP, which in turn activates PKA [19] . importantly, the Ca 2+ /AC/cAMP/PKA pathway acts upstream of DLK-1 to promote axon regeneration. Second, a very recent study [20] has shown that the core apoptotic executioner protein CED-3 (caspase) and its activator CED-4 (Apaf-1) play surprising roles in controlling axon regeneration by acting upstream of DLK-1. interestingly, in the same study, the CED-4/CED-3 pathway was also placed downstream of axotomy-induced local Ca 2+ influx.
In the same RNAi screen using a β-spectrin mutant that identified DLK-1 [9] , another MAPKKK, MLK-1, was shown to control axon regeneration in parallel with the DLK-1 pathway [21] (Fig. 2) . Downstream mediators of MLK-1 are MEK-1 and KGB-1 (JNK). JNK signaling is also upregulated in Drosophila upon axonal injury in a brain needle-injury model [22] and a crushed larval ventral nerve cord model [23] .
in a Drosophila whole-brain culture model, expression of dominant-negative JNK blocks axon regeneration, whereas expression of the constitutively active form of Drosophila JNK kinase induces robust regrowth of the severed axons, one-third of which even extend to re-enter the target area [24] .
Because JNK is well known to regulate axonal microtubules in mammalian neurons during axon growth [25] [26] [27] [28] , it is likely that the MLK-1/MEK-1/KGB-1 pathway in C. elegans also targets microtubules for controlling axon regeneration.
Additional studies in C. elegans have shown that SVH-1, a homolog of mammalian hepatocyte growth factor and its receptor SVH-2 function upstream of the MLK-1 pathway to promote axon regeneration [29] , whereas SVH-3, a homolog of mammalian fatty acid amide hydrolase, inhibits axon regeneration through antagonizing the MLK-1 pathway [30] . in summary, two MAP kinase pathways function in C.
elegans to regulate naturally-occurring axon regeneration, and both pathways mainly act locally at the axon to control microtubule reorganization and growth-cone remodeling upon axotomy (Fig. 2) .
Signaling at the Neuronal Soma
The large-scale genetic screen in C. elegans [18] has also identified several transcription factors that may regulate axon regeneration by modulating gene expression in the soma. However, no detailed study of these molecules has been reported yet. one unexpected player that may function to control gene expression during C. elegans axon regeneration is the protein Notch [31] . Specifically, Notch acts to regulate the axon regeneration of zebrafish retinal ganglion cells [32] . A subsequent study showed that KLF6/7 regulate axon regeneration by controlling the transcription of the tubulin isoform Tuba1a [33] . How Notch signaling and KLF6/7 are regulated by upstream signaling pathways is not known. regeneration of the central axons is greatly enhanced [34] .
Recent studies found that this effect could be achieved if the peripheral axotomy was performed at the same time [35] or even after the central axotomy [36] . These results indicate that peripheral axotomy increases the intrinsic ability of DRG neurons to support axon regeneration by activation of a transcription-dependent regeneration program and the subsequent expression of a group of regenerationassociated genes in the soma [37] . 
novel in vivo electroporation
technique has recently been developed that allows specific manipulation of multiple gene expression in adult DRG neurons simultaneously [38] , providing a potentially useful tool for the in vivo dissection of pathways regulating mammalian axon regeneration.
in contrast to the in vivo model, adult DRG neurons can readily be cultured and therefore have been widely used to study axon growth from mature neurons in vitro [39] . Depending on the experimental procedure or the culture conditions, in vitro axon growth from adult DRG neurons can be stimulated and regulated by distinct mechanisms and signaling pathways [40, 41] . Therefore, to study regeneration pathways, it is important to use an in vitro model that mimics in vivo peripheral axotomy-induced axon regeneration. if an in vivo peripheral nerve injury is performed prior to culture, the cultured DRG neurons are able to extend long axons overnight. Such peripheral axotomy-induced regenerative axon growth often starts within a few hours after cell plating and the axons extend with few branches (elongation mode) [41] . in contrast, naïve (uninjured) DRG neurons cultured at low density grow few axons in the first 24 h in the absence of growth factors.
Addition of growth factors (e.g. NGF or GDNF) induces robust axon growth. However, such NGF-induced growth is regulated by a different pathway from that of peripheral axotomy-induced axon growth (see below) and the processes show a highly-branched morphology (sprouting mode) [39, 41] . Together, this evidence suggests that 
Signaling at the Growth Cone
one way to spatially dissect signaling pathways in neurons is the two-compartmental culture system that separates somata from axons both physically and chemically, such as the traditional Campenot chamber [42, 43] and the recentlydeveloped microfluidic-based chambers [44, 45] . Using such approaches, previous studies have shown that Pi3K and ERK, two major signaling molecules mediating NGFinduced axon growth [46] , are both required locally at the axon to control axon growth from developing sensory neurons [47] . To our knowledge, no similar study has been reported for regenerative axon growth from adult neurons.
However, an interesting observation of peripheral axotomyinduced regenerative axon growth from adult DRG neurons is that active gene transcription is not required for axon growth in the first 24 h [41, 48] . Such a property therefore provides a unique opportunity for investigating transcription-independent signaling mechanisms that specifically regulate local axon assembly. In contrast to that of developing DRG neurons, regenerative axon growth from adult DRG neurons does not require Pi3K and ERK activity for local axon assembly [40, 41] , indicating growth factorindependent pathways for PNS axon regeneration. indeed, application of a function-blocking antibody to NGF is unable to inhibit peripheral nerve regeneration [49] , providing solid evidence that in vivo peripheral axon regeneration does not require NGF. Consistent with this, adult DRG neurons undergoing peripheral axotomy are able to extend long axons in culture in the absence of growth factors [41] .
instead, activation of integrin signaling by laminin is sufficient to induce robust axon growth from these pre-axotomized DRG neurons, suggesting that integrin signaling plays a key role in peripheral nerve regeneration.
indeed, laminin isoforms are highly enriched in peripheral nerve pathways [50] , and loss of integrin subtype alpha 7
impedes facial nerve regeneration in vivo after a lesion [51] .
Downstream of integrin signaling, regenerative axon growth is mediated by the inactivation of glycogen synthase 3 (GSK3) [41] , which in turn controls growth-cone microtubule assembly via the microtubule-binding protein adenomatous polyposis coli (APC) and CLiP-associating proteins (CLASPs) [52] . Both APC and CLASPs are microtubule plusend tracking proteins that stabilize dynamic microtubules without interfering with microtubule polymerization [53] .
Down-regulation of CLASPs in adult DRG neurons reduces tubulin acetylation/microtubule stability and inhibits sensory axon regeneration in vivo [52] , providing strong evidence that regulation of axonal microtubule dynamics is important for successful axon regeneration.
in addition to microtubule-binding proteins, microtubule dynamics are also regulated by post-translational modification, in particular acetylation, which is associated with increased microtubule stabilization [54] . A recent study showed that peripheral axotomy induces tubulin deacetylation and therefore increases microtubule dynamics in axons at the proximal injury site [55] . Together, these studies highlight the important role of axonal microtubule dynamics in the regulation of mammalian axon regeneration. Notably, either downregulation of CLASPs which reduces tubulin acetylation [52] , or inhibition of HDAC which increases tubulin acetylation [55] , blocks sensory axon regeneration, suggesting that a balance of microtubule stabilization and dynamics is required for optimal axon regeneration.
Signaling at the Neuronal Soma
Gene expression at the soma, which provides the raw materials for axon assembly, is necessary for sustained axon growth. The regeneration-associated genes identified by genetic profiling include many transcription factors, such as c-Jun, Stat3, ATF3, Smad1, p53, and SoX11 (Fig. 3) . it is well recognized that these factors control the transcription of genes that support peripheral axotomyinduced axon regeneration [56, 57] . How upstream signaling pathways regulate the expression and/or activation of these factors is less clear.
Genetic deletion of Pten and the subsequent activation of the Pi3K-Akt pathway have recently been
shown to drastically promote the intrinsic axon growth of mature mammalian CNS neurons by controlling the mTor pathway [1, 2, 4] . Does the Pi3K pathway play any role in the regulation of intrinsic axon growth during naturallyoccurring PNS axon regeneration? in a mutant mouse line, where p110δ, the endogenous catalytic subunit of Pi3K, is replaced with an inactive mutation, sensory axon regeneration is greatly impaired [58] . Because the Pi3K pathway is not required for local axon assembly during sensory axon regeneration [40, 41] , this result suggests that by GSK3, which is a major downstream signaling mediator of Pi3K [57] . Future study using a compartmentalized culture system is required to provide a more definitive answer regarding the role of Pi3K in the regulation of gene expression during mammalian axon regeneration.
As discussed earlier, in C. elegans, DLK-1 regulates axon regeneration mainly by acting at the growth cone (Fig.   2 ). in contrast, recent studies of DLK knockout mice have shown that mammalian DLK controls axon regeneration via the activation of c-Jun and Stat3 [59, 60] , suggesting a role of DLK in controlling gene expression in the soma (Fig. 3) .
Further experiments showed that DLK does not directly activate Stat3 but regulates the retrograde transport of activated Stat3 from the injury site [59] . Although not tested directly, it is likely that DLK regulates c-Jun activation through JNK. To date, however, there is no direct evidence showing that DLK regulates peripheral axotomy-induced gene expression, and future genetic-profiling studies of DLK knockout mice may provide an answer. it should be noted that besides regulating transcription factors, DLK-JNK has also been shown to regulate developmental axon growth by controlling microtubule stability at the growth cone [61] . Whether DLK-JNK signaling also regulates axonal microtubules during mammalian axon regeneration awaits further study. Moreover, a new study [62] found that Stat3 controls microtubule stability locally in the axon independent of its transcriptional activity, raising the possibility that DLK-Stat3 activated at the injury site after peripheral axotomy may also play a local role in the regulation of axon regeneration. Together, the evidence to date suggests that DLK signaling regulates mammalian axon regeneration by controlling gene expression in the 
Summary and Future Directions
Successful axonal regeneration in the injured nervous system is a complex process that involves coordinated regulation of gene expression in the soma and cytoskeleton assembly at the growth cone. The emergence of nonmammalian injury and regeneration models has provided new opportunities to identify signaling pathways that regulate naturally-occurring axon regeneration. Because the genetic approaches used in the non-mammalian models are not available for mammalian models, it is not practical to perform similar large-scale genetic screening in mice to identify mammalian axon regeneration pathways.
Therefore, verifying if signaling pathways identified in the non-mammalian models also function in mammalian models will be the focus of future studies. The recentlydeveloped technique of in vivo electroporation of adult sensory neurons [38] would make such studies more feasible and efficient.
Most of the axon regeneration pathways identified to date are located at the growth cone (see Figs. 2 and 3), and much less is known about signaling pathways functioning at the soma to control gene expression.
Because the manipulation of gene expression (transcription or translation) has proven effective in promoting CNS axon regeneration [1] [2] [3] [4] [5] , elucidating the signaling pathways that regulate gene expression during naturally-occurring axon regeneration in the mammalian PNS should become a major focus of axon regeneration research.
